Alvotech (ALVO) Accounts Payables (2020 - 2026)
Alvotech (ALVO) posted Accounts Payables of $97.9 million for Q1 2026, down 22.41% on a QoQ basis from $126.1 million in Q4 2025, and up 44.16% year-over-year from $67.9 million in Q1 2025.
Alvotech (ALVO) Accounts Payables (2020 - 2026) Analysis & Trends
Alvotech's Accounts Payables history runs 7 years deep, the most recent figure standing at $97.9 million for Q1 2026.
- Quarterly Accounts Payables rose 44.16% year-over-year to $97.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $97.9 million (up 44.16% YoY) and the FY2025 annual result came in at $126.1 million, up 87.89% from the prior year.
- Accounts Payables was $97.9 million for Q1 2026 at Alvotech, down from $126.1 million in the prior quarter.
- Across five years, Accounts Payables topped out at $126.1 million in Q4 2025 and bottomed at $29.8 million in Q1 2023.
- A 5-year average of $67.8 million and a median of $62.8 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables retreated 16.68% — and 2025, when it surged 87.89%.
- Alvotech's Accounts Payables stood at $49.2 million in 2022, then surged by 63.79% to $80.6 million in 2023, then slipped by 16.68% to $67.1 million in 2024, then jumped by 87.89% to $126.1 million in 2025, then dropped by 22.41% to $97.9 million in 2026.
- Business Quant data shows ALVO's Accounts Payables at $97.9 million in Q1 2026, $126.1 million in Q4 2025, and $91.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 97.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.87 Mn |
| Dec 31, 2025 | 126.12 Mn |
| Sep 30, 2025 | 91.63 Mn |
| Jun 30, 2025 | 84.28 Mn |
| Mar 31, 2025 | 67.89 Mn |
| Dec 31, 2024 | 67.13 Mn |
| Sep 30, 2024 | 57.72 Mn |
| Jun 30, 2024 | 58.57 Mn |
| Mar 31, 2024 | 50.18 Mn |
| Dec 31, 2023 | 80.56 Mn |
| Jun 30, 2023 | 43.93 Mn |
| Mar 31, 2023 | 29.77 Mn |
| Dec 31, 2022 | 49.19 Mn |
| Jun 30, 2022 | 44.73 Mn |
| Dec 31, 2021 | 28.59 Mn |
| Dec 31, 2020 | 11.96 Mn |